Prof.Dr.med. ID: 71876
Volkmar Müller
Publications
- 2010
Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
Henningsen, M., Köhler, N., Kersten, J. F., Milde-Langosch, K., Beck, K., Höller, S., Müller, V., Witzel, I., Jänicke, F. & Kilic, E., 2010, In: DIS MARKERS. 28, 2, p. 71-78 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.
Müller, V., Thomssen, C., Schmidt, M., Glados, M., Jackisch, C., Heilmann, V., Hinke, A., Lehnert, A., Borowicz, H. & Möbus, V., 2010, In: BMC CANCER. 10, p. 430Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: cardiac safety and efficacy data from the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) trial.
Untch, M., Muscholl, M., Tjulandin, S., Jonat, W., Meerpohl, H-G., Lichinitser, M., Manikhas, A. G., Coumbos, A., Kreienberg, R., Andreas, D. B., Harbeck, N., Jackisch, C., Müller, V., Pauschinger, M., Thomssen, C., Lehle, M., Catalani, O. & Lück, H-J., 2010, In: J CLIN ONCOL. 28, 9, p. 1473-1480 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
Fehm, T., Müller, V., Aktas, B., Janni, W., Schneeweiss, A., Stickeler, E., Lattrich, C., Löhberg, C. R., Solomayer, E., Rack, B., Riethdorf, S., Klein, C., Schindlbeck, C., Brocker, K., Kasimir-Bauer, S., Wallwiener, D. & Pantel, K., 2010, In: BREAST CANCER RES TR. 124, 2, p. 403-412 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.
Müller, V., Alix-Panabières, C. & Pantel, K., 2010, In: EUR J CANCER. 46, 7, p. 1189-1197 7.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.
Witzel, I., Loibl, S., von Minckwitz, G., Mundhenke, C., Huober, J., Hanusch, C., Henschen, S., Hauschild, M., Lantzsch, T., Tesch, H., Latos, K., Just, M., Hilfrich, J., Barinoff, J., Zu Eulenburg, C. G., Roller, M., Untch, M. & Müller, V., 2010, In: BREAST CANCER RES TR. 123, 2, p. 437-445 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.
Choschzick, M., Wölber, L., Hess, S., Zu Eulenburg, C. G., Schwarz, J., Simon, R., Mahner, S., Jänicke, F. & Müller, V., 2010, In: VIRCHOWS ARCH. 456, 5, p. 483-490 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
Wölber, L., Jung, S., Zu Eulenburg, C. G., Müller, V., Schwarz, J., Jänicke, F. & Mahner, S., 2010, In: EJSO-EUR J SURG ONC. 36, 6, p. 583-588 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.
Lebeau, A., Turzynski, A., Braun, S., Behrhof, W., Fleige, B., Schmitt, W. D., Grob, T., Burkhardt, L., Hölzel, D., Jackisch, C., Thomssen, C., Müller, V. & Untch, M., 2010, In: J CLIN ONCOL. 28, 20, p. 3264-3270 20.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.
Wölber, L., Müller, V., Zu Eulenburg, C. G., Schwarz, J., Carney, W., Jänicke, F., Milde-Langosch, K. & Mahner, S., 2010, In: GYNECOL ONCOL. 117, 2, p. 183-188 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
Schröder, C., Schumacher, U., Müller, V., Wirtz, R. M., Streichert, T., Richter, U., Wicklein, D. & Milde-Langosch, K., 2010, In: EUR J CANCER. 46, 9, p. 1650-1660 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.
Mahner, S., Wölber, L., Zu Eulenburg, C. G., Schwarz, J., Carney, W., Jänicke, F., Milde-Langosch, K. & Müller, V., 2010, In: BMC CANCER. 10, p. 139Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2009
Adjuvante Chemotherapie und Antikörpertherapie
Müller, V. & Stickeler, E., 2009, Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. Zuckerschwerdt Verlag, p. 23-40 18 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
Clinical Relevance of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients
Müller, V., Fehm, T., Janni, W., Gebauer, G., Solomayer, E. & Pantel, K., 2009, In: BREAST CARE. 4, 5, p. 333-338 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection and Characterization of Disseminated Tumor Cells present in Bone Marrow of Cancer Patients
Riethdorf, S., Müller, V., Alix-Panabières, C. & Pantel, K., 2009, Bone and Cancer. Springer London, p. 103-117 15 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
Knippen, S., Löning, T., Müller, V., Schröder, C., Jänicke, F. & Milde-Langosch, K., 2009, In: ANTICANCER RES. 29, 1, p. 183-189 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Expression and prognostic value of L1-CAM in breast cancer.
Schröder, C., Schumacher, U., Fogel, M., Feuerhake, F., Müller, V., Wirtz, R. M., Altevogt, P., Krenkel, S., Jänicke, F. & Milde-Langosch, K., 2009, In: ONCOL REP. 22, 5, p. 1109-1117 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Gene amplification in ductal carcinoma in situ of the breast.
Burkhardt, L., Grob, T., Hermann, I., Burandt, E. C., Choschzick, M., Jänicke, F., Müller, V., Bokemeyer, C., Simon, R., Sauter, G., Wilczak, W. & Lebeau, A., 2009, In: BREAST CANCER RES TR.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.
Rody, A., Karn, T., Ruckhäberle, E., Müller, V., Gehrmann, M., Solbach, C., Ahr, A., Gätje, R., Holtrich, U. & Kaufmann, M., 2009, In: BREAST CANCER RES TR. 113, 3, p. 457-466 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.
Rody, A., Karn, T., Ruckhäberle, E., Hanker, L., Metzler, D., Müller, V., Solbach, C., Ahr, A., Gätje, R., Holtrich, U. & Kaufmann, M., 2009, In: EUR J CANCER. 45, 3, p. 405-413 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Minimal Residual Cancer and its Clinical Relevance
Rack, B., Müller, V., Kasimir-Bauer, S., Schindlbeck, C. & Janni, W., 2009, In: CURR BREAST CANCER R. 1, p. 198-206Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic impact of thymidine phosphorylase expression in breast cancer - Comparison of microarray and immunohistochemical data.
Ruckhäberle, E., Karn, T., Engels, K., Turley, H., Hanker, L., Müller, V., Schmidt, M., Ahr, A., Gaetje, R., Holtrich, U., Kaufmann, M. & Rody, A., 2009, In: EUR J CANCER.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2008
Expression des "activated leukocyte cell adhesion molecule" im Mammakarzinom. Prädiktivität für das Ansprechen auf eine taxanfreie Chemotherapie
Kilic, E., Milde-Langosch, K., Müller, V., Wirtz, R. & Ihnen, M., 11.2008, In: PATHOLOGE. 29 Suppl 2, p. 347-52 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Nachweis von Metastasen bei Patientinnen mit Mamma - karzinom Vergleich von FDG-PET mit Röntgen-Thorax, Oberbauchsonographie und Skelett szintigraphie
Dose-Schwarz, J., Mahner, S., Schirrmacher, S., Jenicke, L., Müller, V., Habermann, C. & Brenner, W., 01.01.2008, In: NUKLEARMED-NUCL MED. 47, 3, p. 97-103 7 p., 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer.
Schrohl, A-S., Müller, V., Christensen, I. J., Pantel, K., Thomssen, C. & Bruenner, N., 2008, In: TUMOR BIOL. 29, 3, p. 181-187 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
[Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy]
Kilic, E., Milde-Langosch, K., Müller, V., Wirtz, R. & Henningsen, M., 2008, In: PATHOLOGE. 29, 2, p. 347-352 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
HER2 as marker for the detection of circulating tumor cells.
Müller, V. & Pantel, K., 2008, In: BREAST CANCER RES TR.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance.
Fehm, T., Müller, V., Alix-Panabières, C. & Pantel, K., 2008, In: BREAST CANCER RES. 10, 1, p. 1 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck, N., Nimmrich, I., Hartmann, A., Ross, J. S., Cufer, T., Grützmann, R., Kristiansen, G., Paradiso, A., Hartmann, O., Margossian, A., Martens, J., Schwope, I., Lukas, A., Müller, V., Milde-Langosch, K., Nährig, J., Foekens, J., Maier, S., Schmitt, M. & Lesche, R., 2008, In: J CLIN ONCOL. 26, 31, p. 5036-5042 31.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Henningsen, M., Müller, V., Wirtz, R. M., Schröder, C., Krenkel, S., Witzel, I., Lisboa, B. W., Jänicke, F. & Milde-Langosch, K., 2008, In: BREAST CANCER RES TR. 112, 3, p. 419-427 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Trastuzumab in pregnancy associated with poor fetal outcome.
Witzel, I., Müller, V., Harps, E., Jänicke, F. & De Wit, M., 2008, In: ANN ONCOL. 19, 1, p. 191-192 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm, T., Müller, V., Marches, R., Klein, G., Gueckel, B., Neubauer, H., Solomayer, E. & Becker, S., 2008, In: APMIS. 116, 7-8, p. 742-753 7-8.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2007
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.
Schwarzenbach, H., Müller, V., Beeger, C., Gottberg, M., Stahmann, N. & Pantel, K., 2007, In: BREAST CANCER RES. 9, 5, p. 66 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Current status in human breast cancer micrometastasis.
Alix-Panabières, C., Müller, V. & Pantel, K., 2007, In: CURR OPIN ONCOL. 19, 6, p. 558-563 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
Schunke, D., Span, P., Ronneburg, H., Dittmer, A., Vetter, M., Holzhausen, H-J., Kantelhardt, E., Krenkel, S., Müller, V., Sweep, F. C. G. J., Thomssen, C. & Dittmer, J., 2007, In: CANCER RES. 67, 22, p. 10694-10702 22.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection and characterization of putative metastatic precursor cells in cancer patients.
Alix-Panabières, C., Vendrell, J-P., Pellé, O., Rebillard, X., Riethdorf, S., Müller, V., Fabbro, M. & Pantel, K., 2007, In: CLIN CHEM. 53, 3, p. 537-539 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., Jackson, S., Gornet, T., Cristofanilli, M. & Pantel, K., 2007, In: CLIN CANCER RES. 13, 3, p. 920-928 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.
Fehm, T., Becker, S., Duerr-Stoerzer, S., Sotlar, K., Müller, V., Wallwiener, D., Lane, N., Solomayer, E. & Uhr, J., 2007, In: BREAST CANCER RES. 9, 5, p. 74 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
Maier, S., Nimmrich, I., Koenig, T., Eppenberger-Castori, S., Bohlmann, I., Paradiso, A., Spyratos, F., Thomssen, C., Müller, V., Nährig, J., Schittulli, F., Kates, R., Lesche, R., Schwope, I., Kluth, A., Marx, A., Martens, J. W. M., Foekens, J. A., Schmitt, M. & Harbeck, N., 2007, In: EUR J CANCER. 43, 11, p. 1679-1686 11.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2006
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
Fehm, T., Braun, S., Müller, V., Janni, W., Gebauer, G., Marth, C., Schindlbeck, C., Wallwiener, D., Borgen, E., Naume, B., Pantel, K. & Solomayer, E., 2006, In: CANCER-AM CANCER SOC. 107, 5, p. 885-892 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.
Witzel, I., Thomssen, C., Krenkel, S., Wilczak, W., Bubenheim, M., Pantel, K., Neumann, R., Jänicke, F. & Müller, V., 2006, In: INT J BIOL MARKER. 21, 3, p. 131-140 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance.
Wölfle, U., Müller, V. & Pantel, K., 2006, In: FUTURE ONCOL. 2, 4, p. 553-561 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.
Müller, V., Witzel, I., Pantel, K., Krenkel, S., Lück, H. J., Neumann, R., Keller, T., Dittmer, J., Jänicke, F. & Thomssen, C., 2006, In: ANTICANCER RES. 26, 2, p. 1479-1487 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Recent translational research: circulating tumor cells in breast cancer patients.
Müller, V., Hayes, D. F. & Pantel, K., 2006, In: BREAST CANCER RES. 8, 5, p. 110 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2004
Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer
Schwarzenbach, H., Müller, V., Stahmann, N. & Pantel, K., 01.06.2004, In: ANN NY ACAD SCI. 1022, p. 25-32 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostische und prädiktive Faktoren bei Patientinnen mit Mammakarzinom: Management des Mammakarzinoms
Müller, V. & Jänicke, F., 2004, Management des Mammakarzinoms. Kreienberg, R. (ed.). Heidelberg, New York: Springer, p. xxResearch output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
Sentinel Lymph Node Dissection and Micrometastasis Detection in Bone Marrow and Lymph Nodes: Molecular Oncology of Breast Cancer
Müller, V., Kasimir-Bauer, S. & Pantel, K., 2004, Molecular Oncology of Breast Cancer. Ross, J. S. & Hortobagyi, G. (eds.). Jones and Bartlett, p. 117-127 11 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
- 2003
Clinical Relevance of Micrometastatic Disease in Patients with Solid Tumors
Muller, V. & Pantel, K., 03.2003, In: AM J CANCER. 2, 2, p. 77-86Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Correlation on serum HER-2/neu extracellular domain levels in metastatic breast cancer with the expression of HER-2/neu determined by immunohistochemistry in primary tumors
Witzel, I., Thomssen, C., Pantel, K., Neumann, R., Carney, W., Loening, T., Jaenicke, F. & Müller, V., 2003, In: BREAST CANCER RES TR. 82, Suppl. 1, p. S 143Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection and characterisation of occult metastatic cells in bone marrow of breast cancer patients: Micrometastasis
Braun, S., Müller, V. & Pantel, K., 2003, Micrometastasis. Pantel, K. (ed.). Kluwer Academic Press, p. 47-66 20 p. (Cancer Metastasis-Biology and Treatment).Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review